PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31300540-6	2019	We validated that inhibitors of these druggable target genes, including the CDK1/CDK2 inhibitor dinaciclib, had antiproliferative and cytotoxic effects selectively on mouse prostate cells with knockdown of Chd1 and Map3k7.	dinaciclib	96-106	chromodomain helicase DNA binding protein 1	Mus musculus	206-210	
31300540-7	2019	Dinaciclib had stronger effects on prostate cells with suppression of Map3k7 independent of Chd1 and also compared with cells without loss of Map3k7.	dinaciclib	0-10	chromodomain helicase DNA binding protein 1	Mus musculus	92-96